| 序号 | 标题 | 次数 | 作者 | 发布时间 |
|---|---|---|---|---|
| 76951 | m-PEG6-CH2CH2CHO | 66 | zyl | 2024-12-13 |
| 76952 | MAK683-CH2CH2COOH | 129 | zyl | 2024-12-13 |
| 76953 | (S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc | 85 | zyl | 2024-12-13 |
| 76954 | (S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-CH2-Me-PIP-Boc | 66 | zyl | 2024-12-13 |
| 76955 | MC-VC-PABC-amide-PEG1-CH2-CC-885 | 56 | zyl | 2024-12-13 |
| 76956 | Azido-PEG4-(CH2)3OH | 68 | zyl | 2024-12-13 |
| 76957 | 慢病毒载体的来源及结构，构建慢病毒表达载体 | 830 | axc | 2024-12-13 |
| 76958 | Ald-CH2-PEG8-azide | 72 | zyl | 2024-12-13 |
| 76959 | m-PEG4-(CH2)6-Phosphonic acid | 75 | zyl | 2024-12-13 |
| 76960 | Ald-CH2-PEG5-Boc | 61 | zyl | 2024-12-13 |
| 76961 | 通过构建shRNA慢病毒质粒实现基因的敲减，慢病毒载体的发展过程 | 514 | axc | 2024-12-13 |
| 76962 | Fmoc-Gly-NH-CH2-O-Cyclopropane-CH2COOH | 72 | zyl | 2024-12-13 |
| 76963 | Gly-NH-CH2-Boc | 98 | zyl | 2024-12-13 |
| 76964 | Difluorocyclooctyne-CH2-benzoic acid | 91 | zyl | 2024-12-13 |
| 76965 | NH2-PEG2-CH2-Boc | 98 | zyl | 2024-12-13 |
| 76966 | shRNA慢病毒载体构建及细胞系筛选 | 420 | axc | 2024-12-13 |
| 76967 | Hydroxy-PEG4-(CH2)2-Boc | 77 | zyl | 2024-12-13 |
| 76968 | Thalidomide-5-O-CH2-COOH | 102 | zyl | 2024-12-13 |
| 76969 | Thalidomide-NH-CH2-COOH | 102 | zyl | 2024-12-13 |
| 76970 | Amino-PEG10-CH2-Boc | 110 | zyl | 2024-12-13 |
| 76971 | Hydroxy-PEG6-CH2-Boc | 63 | zyl | 2024-12-13 |
| 76972 | Tos-PEG4-CH2-Boc | 74 | zyl | 2024-12-13 |
| 76973 | m-PEG4-CH2-alcohol | 64 | zyl | 2024-12-13 |
| 76974 | β-Naphthoflavone-CH2-OH | 117 | zyl | 2024-12-13 |
| 76975 | 利用慢病毒快速构建IPS稳转株，定制服务 | 122 | axc | 2024-12-13 |
| 76976 | Methyl isonicotinate-(CH2)2-COOH | 70 | zyl | 2024-12-13 |
| 76977 | HO-PEG24-CH2COOtBu | 63 | zyl | 2024-12-13 |
| 76978 | Hydroxy-PEG10-CH2-Boc | 118 | zyl | 2024-12-13 |
| 76979 | Fmoc-Gly-NH-CH2-acetyloxy | 80 | zyl | 2024-12-13 |
| 76980 | Thalidomide-5-CH2-NH2 hydrochloride | 85 | zyl | 2024-12-13 |
| 76981 | MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH-d5 | 74 | zyl | 2024-12-13 |
| 76982 | 通过慢病毒介导的基因过表达，定制服务，实验步骤 | 126 | axc | 2024-12-13 |
| 76983 | 基因敲低、敲除、过表达载体的构建 | 1271 | axc | 2024-12-13 |
| 76984 | 质粒以及慢病毒的基因过表达方法 | 757 | axc | 2024-12-13 |
| 76985 | CRISPR KI技术构建基因过表达细胞株 | 203 | axc | 2024-12-13 |
| 76986 | CRISPRa系统构建基因过表达细胞株，CRISPRa技术优势 | 192 | axc | 2024-12-13 |
| 76987 | PB转座子系统构建基因过表达细胞，技术介绍 | 342 | axc | 2024-12-13 |
| 76988 | 慢病毒介导的稳定细胞株构建流程 | 513 | axc | 2024-12-13 |
| 76989 | 慢病毒载体介导过表达和敲低细胞株的建立 | 240 | axc | 2024-12-13 |
| 76990 | 七肽DOTA-YLYEIAR,1262403-90-6 | 117 | h | 2024-12-12 |
| 76991 | DOTA-CH2-Ph-azide(HCl salt) | 146 | h | 2024-12-12 |
| 76992 | NOTA-PEG-TAT,大环配体NOTA-聚乙二醇-TAT | 94 | h | 2024-12-12 |
| 76993 | DOTA-Lys-Cys-Acid,1180007-00-4 | 114 | h | 2024-12-12 |
| 76994 | DOTA-NHS ester,CAS170908-81-3 | 87 | h | 2024-12-12 |
| 76995 | C18-PEG-Lactoferrin； 十八烷基-聚乙二醇-乳铁蛋白 | 303 | kx | 2024-12-12 |
订单热线
400-6966-012
齐岳微信公众号
官方微信All Rights Reserved 陕ICP备20008861号
技术支持：硅峰网络
库存查询